New FDA-approved immunizations are crucial for protecting infants from RSV, a leading cause of hospitalization for babies ...

Among children younger than 2, the preventive effects of nirsevimab against RSV were maintained for up to 12 months after administration.

The vaccine became available in 2023 and has quickly gained usage in the Mountain West.

It has been a brutal viral season, but as RSV cases surged in New York​, Northwell Health doctors say infant hospitalizations remained down, thanks to a fairly new vaccine.

Here’s our weekly round-up of what illnesses are spreading the most in Metro Detroit communities, according to our local ...

This current respiratory illness season has brought a sharp increase in the spread of infectious diseases. Here in South ...

Respiratory syncytial virus (RSV) is spreading across the country, but it’s not too late to take steps to protect babies from ...

When Michelle Pratt's twins were born, she learned they didn't qualify for an antibody shot that can prevent RSV. While Pratt ...

The NIRSE-GAL study, conducted in Galicia, Spain, is the first prospective real-world population study to evaluate the impact ...

Human challenge trials offer a complementary approach. By safely and deliberately exposing healthy adult volunteers to a well characterised virus under controlled conditions, researchers can generate ...

Beyfortus study published in The Lancet Infectious Diseases shows benefit for infants beyond first RSV season . First study showing that infants immunized against RSV in their fir ...

The number of babies admitted to intensive care with respiratory syncytial virus (RSV) has fallen significantly largely due ...